| Literature DB >> 33479640 |
Marina A Vodiakova1, Aliya R Sayfutdinova1,2, Ekaterina V Melnikova1, Artem A Goryaev1, Natalia P Sadchikova2, Vladimir I Gegechkori2,3, Vadim A Merkulov1.
Abstract
Donor biological materials and excipients of animal origin are important components in the production of biomedical cell products (BMCPs). Their quality ensures the stability, safety, effectiveness and purity of the final product. This review discusses quality requirements for biological excipients intended for the production of biomedical cell products, in terms of the necessary information that should be included in the BMCP registration dossier during state registration and is subject to expert assessment during quality control. Considering that there is currently no production of biomedical cell products in the Russian Federation, the authors considered international approaches to ensuring the safety of donor material and excipients for the manufacturing of human cell- and tissue-based products (BMCP analogues). This journal is © The Royal Society of Chemistry 2020.Entities:
Year: 2020 PMID: 33479640 PMCID: PMC7580781 DOI: 10.1039/c9md00529c
Source DB: PubMed Journal: RSC Med Chem ISSN: 2632-8682